1160 Examining Criteria in Hypoglossal Nerve Stimulation: A Case Insight

Steven Bean,Venkata Mukkavilli

DOI: https://doi.org/10.1093/sleep/zsae067.01160

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Introduced in 2001, the hypoglossal nerve stimulator (HGNS) is an implantable device designed to treat moderate to severe obstructive sleep apnea (OSA). FDA-approved on May 1, 2014, it offers an alternative for patients unable to benefit from continuous positive airway pressure (CPAP) therapy. However, not all patients may benefit, leading to the establishment of exclusion criteria based on factors such as body mass index, central and/or mixed apnea index >25%, complete concentric palatal collapse, patient age, and certain comorbidities such as neuromuscular and cardiac diseases. It is important to consider these criteria when screening patients to ensure the appropriate use of the device. Here, we present a case illustrating a patient who received a HGNS device according to established criteria but may not have been an ideal candidate.123 Report of case(s) A 55-year-old male with a history of hyperlipidemia, depression, and hypothyroidism status post (s/p) thyroidectomy to treat multinodular goiter, moderate OSA (AHI 16.2 events/hr) s/p uvulopalatopharyngoplasty and failed CPAP tolerance, underwent HGNS implantation. Post-procedure, an abnormal electrocardiogram led to a referral to cardiology, where he was found to have heart failure with a reduced ejection fraction of 20%. A follow-up titration polysomnography showed central events, presumed treatment emergent, following HGNS implantation. He is currently being monitored by cardiology for the optimization of his heart failure. Upon re-evaluation of his initial pre-implantation study, we felt that several of the hypopnea events may have been central hypopneas. Although his OSA is controlled with the HGNS, the patient still has central sleep apnea that is not being treated. Conclusion There is a lack of routine differentiation between central and obstructive hypopneas in current assessments, which poses a potential oversight in patient selection, impacting treatment planning. Central hypopneas should be included when assessing the 25% threshold of central events that would otherwise exclude a patient from receiving treatment. This case highlights the need for more stringent scoring criteria, specifically incorporating central hypopneas, to better screen high-risk patients and identify optimal candidates for hypoglossal nerve stimulation. Support (if any)

neurosciences,clinical neurology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to identify and treat Non - 24 - hour Sleep - Wake Disorder (N24SWD) in sighted adolescents. N24SWD is a rare sleep disorder, which is usually more common in the blind and affects up to 50% of the blind population. However, in sighted people, especially adolescents, this disease is very rare and difficult to diagnose, especially when the patient also has Attention Deficit Hyperactivity Disorder (ADHD) or poor sleep hygiene habits.

The paper presents the case of a 16 - year - old male patient through a specific case report. He has a history of ADHD and insomnia and sought medical treatment due to repeated inappropriate sleep times and excessive daytime sleepiness. He was initially misdiagnosed as having insomnia caused by extensive use of electronic devices before going to bed. After a series of ineffective drug treatments, through two - week sleep diary records, it was found that the patient's sleep pattern was delayed by 1 - 2 hours every day, which was in line with the characteristics of Non - 24 - hour Sleep - Wake Phase Disorder. Finally, the patient received treatment combining timed tasimelteon, bright light therapy and chronotherapy to resynchronize his internal circadian rhythm.

Therefore, this paper emphasizes the importance of identifying N24SWD in sighted individuals and proposes the use of sleep diaries as a cost - effective and low - input intervention measure, which helps to reveal the patient's condition and ensure timely treatment.